The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy

The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy

Abstract Background First-line chemotherapy combined with bevacizumab is one of the standard treatment modes for patients with advanced non-small cell lung cancer (NSCLC). Thoracic radiotherapy (TRT) can provide significant local control and survival benefits to patients during the treatment of adva...

Full description

Bibliographic Details
Main Authors: Feihu Chen, Jiling Niu, Min Wang, Hui Zhu, Zhijun Guo
Format: Article
Language:English
Published: BMC 2024-05-01
Series:Radiation Oncology
Subjects:
Radiation pneumonitis
Bevacizumab
Thoracic radiotherapy
Non-small cell lung cancer
Online Access:https://doi.org/10.1186/s13014-024-02458-x

Internet

https://doi.org/10.1186/s13014-024-02458-x

Similar Items